Helix BioPharma Market Cap

Helix BioPharma has a market cap or net worth of $33.13 million as of December 26, 2024. Its market cap has increased by 8.80% in one year.

Market Cap

33.13M

Enterprise Value

32.97M

Revenue

n/a

Ranking

n/a

PE Ratio

n/a

Stock Price

$0.45

Market Cap Chart

Since August 15, 1995, Helix BioPharma's market cap has increased from 6.90M to 33.13M, an increase of 380.36%. That is a compound annual growth rate of 5.49%.

Market Cap History

Date	Market Cap	% Change
Dec 19, 2024	33.13M	-3.86%
Dec 29, 2023	34.45M	8.43%
Dec 30, 2022	31.77M	-5.92%
Dec 31, 2021	33.77M	-36.31%
Dec 31, 2020	53.03M	-58.92%
Dec 31, 2019	129.09M	214.28%
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro
Dec 31, 2014	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Sandoz Group AG	18.23B
Telix Pharmaceuticals Limited	5.18B
Elekta AB (publ)	2.09B
Ryman Healthcare Limited	1.71B
Verano Holdings Corp.	471.76M
Vireo Growth Inc.	126.59M
Medexus Pharmaceuticals Inc.	48.37M

Market Cap Rankings